Annual Retained Earnings
-$302.52 M
-$177.81 M-142.58%
December 31, 2024
Summary
- As of March 13, 2025, MLYS annual retained earnings is -$302.52 million, with the most recent change of -$177.81 million (-142.58%) on December 31, 2024.
- During the last 3 years, MLYS annual retained earnings has fallen by -$279.51 million (-1214.67%).
- MLYS annual retained earnings is now -8296.28% below its all-time high of -$3.60 million, reached on December 1, 2020.
Performance
MLYS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$302.52 M
-$48.95 M-19.30%
December 31, 2024
Summary
- As of March 13, 2025, MLYS quarterly retained earnings is -$302.52 million, with the most recent change of -$48.95 million (-19.30%) on December 31, 2024.
- Over the past year, MLYS quarterly retained earnings has dropped by -$177.81 million (-142.58%).
- MLYS quarterly retained earnings is now -1214.67% below its all-time high of -$23.01 million, reached on December 1, 2021.
Performance
MLYS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MLYS Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -142.6% | -142.6% |
3 y3 years | -1214.7% | -142.6% |
5 y5 years | -8296.3% | -142.6% |
MLYS Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -1214.7% | at low | -591.7% | at low |
5 y | 5-year | -8296.3% | at low | -1214.7% | at low |
alltime | all time | -8296.3% | at low | -1214.7% | at low |
Mineralys Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$302.52 M(+142.6%) | -$302.52 M(+19.3%) |
Sep 2024 | - | -$253.57 M(+28.6%) |
Jun 2024 | - | -$197.23 M(+26.3%) |
Mar 2024 | - | -$156.22 M(+25.3%) |
Dec 2023 | -$124.71 M | -$124.71 M(+24.3%) |
Sep 2023 | - | -$100.32 M(+29.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | -$77.56 M(+18.6%) |
Mar 2023 | - | -$65.42 M(+23.9%) |
Dec 2022 | -$52.81 M(+129.5%) | -$52.81 M(+20.7%) |
Sep 2022 | - | -$43.74 M(+90.1%) |
Dec 2021 | -$23.01 M(+538.7%) | - |
Dec 2021 | - | -$23.01 M |
Dec 2020 | -$3.60 M | - |
FAQ
- What is Mineralys Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual retained earnings year-on-year change?
- What is Mineralys Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly retained earnings year-on-year change?
What is Mineralys Therapeutics annual retained earnings?
The current annual retained earnings of MLYS is -$302.52 M
What is the all time high annual retained earnings for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual retained earnings is -$3.60 M
What is Mineralys Therapeutics annual retained earnings year-on-year change?
Over the past year, MLYS annual retained earnings has changed by -$177.81 M (-142.58%)
What is Mineralys Therapeutics quarterly retained earnings?
The current quarterly retained earnings of MLYS is -$302.52 M
What is the all time high quarterly retained earnings for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly retained earnings is -$23.01 M
What is Mineralys Therapeutics quarterly retained earnings year-on-year change?
Over the past year, MLYS quarterly retained earnings has changed by -$177.81 M (-142.58%)